https://www.indianpharmapost.com/usfda-approves-bristol-myers-and-2seventy-bios-abecma-for-triple-class-exposed-multiple-myeloma-154862024-04-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/enhertu-approved-in-the-us-as-first-tumour-agnostic-her2-directed-therapy-154872024-04-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/imfinzi-significantly-improved-overall-survival-and-progression-free-survival-in-adriatic-phase-iii-trial-154882024-04-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizers-velsipity-uk-approval-will-raise-competition-in-ulcerative-colitis-market-says-globaldata-154892024-04-06T00:00:00+05:30always0.9